Fact is, every woman is at risk for breast cancer. Today, it is the most common cancer among women, other than skin cancer. And, according to the American Cancer Society, almost 250,000 women will be diagnosed with invasive breast cancer this year and more than 40,000 women will die from the disease. While there is much to be done, more than 2 million breast cancer survivors are alive today.
RECENT DATA FROM THE ANNUAL SAN ANTONIO BREAST CANCER SYMPOSIUM IS SHEDDING NEW LIGHT ON A SURVIVOR’S MOST NAGGING FEAR – WILL MY CANCER COME BACK?
DR. TARA SANFT FROM THE YALE CANCER CENTER SURVIVORSHIP CLINIC IS HERE TO SHARE STUDY FINDINGS THAT RE-DEFINE THE FIVE-YEAR SURVIVAL MILESTONE.
WHY HAS THE FIVE-YEAR MARK TRADITIONALLY BEEN IMPORTANT FOR BREAST CANCER SURVIVORS?
HOW DID THE RESEARCH PRESENTED IN SAN ANTONIO AFFECT THE TRADITIONAL NOTION OF THE FIVE-YEAR SURVIVAL BENCHMARK?
WHAT DOES THIS MEAN FOR WOMEN IN TERMS OF PREDICTING THE LIKELIHOOD OF RECURRENCE AS WELL AS TREATMENT OPTIONS?
WHAT CAN A TEST LIKE THIS DO TO HELP WOMEN MAKE DECISIONS ABOUT THEIR HEALTH?
WHERE CAN WE LEARN MORE?
Tara Sanft, MD, Assistant Professor of Medicine and Medical Director of Adult Survivorship for the Yale Cancer Center Survivorship Clinic will be available to help women learn more about the active roles they can take in charting the course of their treatment journey. She will encourage women to initiate conversations and collaborate with their doctors.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register